Pharma-Bio Capital Prognosis: Signs of Life with $12 Billion in Active Grassroot Projects
Pharma-Bio Capital Prognosis: Signs of Life with $12 Billion in Active Grassroot Projects
Attachment: Top 10 States for Pharma-Biotech Industry Grassroot Plant Construction
SUGAR LAND--May 22, 2008--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Pharmaceutical plant closures continue to make headlines across the country, with thousands of jobs imperiled once the doors finally close. The financial and emotional impact on surrounding communities and residents resulting from the loss of a major employer is almost incalculable. Yet, even as companies continue to shed redundant sites and deem others as unnecessary because of age and myriad other factors, there are definite signs of life in the industry. A recent survey taken from Industrial Info's Pharmaceutical Tracker reveals 132 active grassroot construction projects in North America with an impressive total investment value of just over $12 billion.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects